Marcos G. Couto

Montevideo, MO, Uruguay

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Boron Clusters for Potential Glioblastoma Therapy: Emerging Molecular and Nanostructured Strategies.

Boron Clusters for Potential Glioblastoma Therapy: Emerging Molecular and Nanostructured Strategies.

Journal: Handbook of experimental pharmacology
Published: July 25, 2026

Corrigendum: Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

Corrigendum: Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

Journal: ChemMedChem
Published: April 10, 2026

Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay.

Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay.

Journal: ChemMedChem
Published: March 23, 2026

Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

Nuclear-Targeted Boron-Lapatinib Hybrid for Enhanced Boron Neutron Capture Therapy in Advanced Thyroid Carcinoma.

Journal: ChemMedChem
Published: November 24, 2025

Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity.

Structure-Activity Relationships of closo- and nido-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: October 20, 2025

Unveiling novel pharmacophores and hit compounds for the development of anti-virals to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Unveiling novel pharmacophores and hit compounds for the development of anti-virals to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Journal: Bioorganic chemistry
Published: May 10, 2025

Enhancing Boron Neutron Capture Therapy (BNCT) with Materials Based on COSAN-Functionalized Nanoparticles.

Enhancing Boron Neutron Capture Therapy (BNCT) with Materials Based on COSAN-Functionalized Nanoparticles.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: February 26, 2025

Photoproperties of favipiravir and its 6-substituted analogues: fluorescence controlled through halogen substitution and tautomerism.

Photoproperties of favipiravir and its 6-substituted analogues: fluorescence controlled through halogen substitution and tautomerism.

Journal: Organic & biomolecular chemistry
Published: April 24, 2024

One-step synthesis of favipiravir from Selectfluor® and 3-hydroxy-2-pyrazinecarboxamide in an ionic liquid.

One-step synthesis of favipiravir from Selectfluor® and 3-hydroxy-2-pyrazinecarboxamide in an ionic liquid.

Journal: Organic & biomolecular chemistry
Published: April 17, 2023

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.

A Potential Boron Neutron Capture Therapy Agent Selectively Suppresses High-Grade Glioma: In Vitro and in Vivo Exploration.

Journal: Molecular pharmaceutics
Published: April 04, 2023

Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells.

Exploring the cell death mechanisms of cytotoxic [1,2,3]triazolylcarborane lead compounds against U87 MG human glioblastoma cells.

Journal: Chemical biology & drug design
Published: September 16, 2022

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity.

Sunitinib-Containing Carborane Pharmacophore with the Ability to Inhibit Tyrosine Kinases Receptors FLT3, KIT and PDGFR-β, Exhibits Powerful In Vivo Anti-Glioblastoma Activity.

Journal: Cancers
Published: October 21, 2020
Showing 1-12 of 22

Last Updated: 09/26/2026